- Home
- LXRX vs CNDT Comparison
LXRX vs CNDT Comparison
Compare LXRX & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- CNDT
- Stock Information
- Founded
- LXRX 1995
- CNDT 2016
- Country
- LXRX United States
- CNDT United States
- Employees
- LXRX N/A
- CNDT N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- CNDT Business Services
- Sector
- LXRX Health Care
- CNDT Consumer Discretionary
- Exchange
- LXRX Nasdaq
- CNDT Nasdaq
- Market Cap
- LXRX 428.8M
- CNDT 448.6M
- IPO Year
- LXRX 2000
- CNDT N/A
- Fundamental
- Price
- LXRX $1.52
- CNDT $2.70
- Analyst Decision
- LXRX Buy
- CNDT
- Analyst Count
- LXRX 5
- CNDT 0
- Target Price
- LXRX $3.23
- CNDT N/A
- AVG Volume (30 Days)
- LXRX 2.6M
- CNDT 929.7K
- Earning Date
- LXRX 11-11-2025
- CNDT 11-05-2025
- Dividend Yield
- LXRX N/A
- CNDT N/A
- EPS Growth
- LXRX N/A
- CNDT N/A
- EPS
- LXRX N/A
- CNDT 0.06
- Revenue
- LXRX $58,432,000.00
- CNDT $3,112,000,000.00
- Revenue This Year
- LXRX $67.21
- CNDT N/A
- Revenue Next Year
- LXRX N/A
- CNDT $3.80
- P/E Ratio
- LXRX N/A
- CNDT $43.51
- Revenue Growth
- LXRX 1504.83
- CNDT N/A
- 52 Week Low
- LXRX $0.28
- CNDT $1.90
- 52 Week High
- LXRX $2.18
- CNDT $4.90
- Technical
- Relative Strength Index (RSI)
- LXRX 70.28
- CNDT 42.92
- Support Level
- LXRX $1.28
- CNDT $2.72
- Resistance Level
- LXRX $1.42
- CNDT $2.83
- Average True Range (ATR)
- LXRX 0.10
- CNDT 0.11
- MACD
- LXRX 0.02
- CNDT -0.02
- Stochastic Oscillator
- LXRX 81.00
- CNDT 10.29
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.